Literature DB >> 20925993

Patient perceptions concerning pain management in the treatment of rheumatoid arthritis.

P Taylor1, B Manger, J Alvaro-Gracia, R Johnstone, J Gomez-Reino, E Eberhardt, F Wolfe, S Schwartzman, N Furfaro, A Kavanaugh.   

Abstract

Previous qualitative studies have revealed discrepancies between patients' and physicians' perceptions of rheumatoid arthritis (RA) and its treatment. Questionnaires were administered to 2795 patients with RA (756 from Europe; 2039 from the USA) to measure patients' perceptions regarding pain management in RA. Although the majority of patients reported their RA as somewhat-to-completely controlled, 75% of European and 82% of US patients reported their pain as moderate-to-severe in the previous 2 months. The majority of European (60%) and US (65%) patients reported dissatisfaction with their arthritis pain. Patients' pain levels corresponded with their disease severity. A higher percentage of patients who reported severe pain were being treated for depression than those who had moderate or mild pain. Patients in the USA rated pain relief as the top required benefit from their RA medication. A comprehensive examination of patients' perspectives regarding pain could lead to better patient care and pain management strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20925993     DOI: 10.1177/147323001003800402

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  54 in total

1.  Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up.

Authors:  M Björk; L Trupin; I Thyberg; P Katz; E Yelin
Journal:  Scand J Rheumatol       Date:  2011-09-21       Impact factor: 3.641

Review 2.  A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process.

Authors:  Jaymin Upadhyay; Christian Geber; Richard Hargreaves; Frank Birklein; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2017-08-12       Impact factor: 8.989

3.  IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.

Authors:  Niels Eijkelkamp; Cristine Steen-Louws; Sarita A Y Hartgring; Hanneke L D M Willemen; Judith Prado; Floris P J G Lafeber; Cobi J Heijnen; C E Hack; Joel A G van Roon; Annemieke Kavelaars
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

4.  Pain management: Opioids for RA: a clinical dilemma.

Authors:  Winfried Häuser; Mary-Ann Fitzcharles
Journal:  Nat Rev Rheumatol       Date:  2017-08-03       Impact factor: 20.543

5.  Immune regulation of pain: Friend and foe.

Authors:  Annemieke Kavelaars; Cobi J Heijnen
Journal:  Sci Transl Med       Date:  2021-11-10       Impact factor: 17.956

Review 6.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

Review 7.  Pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 8.  Lipid rafts in glial cells: role in neuroinflammation and pain processing.

Authors:  Yury I Miller; Juliana M Navia-Pelaez; Maripat Corr; Tony L Yaksh
Journal:  J Lipid Res       Date:  2019-12-20       Impact factor: 5.922

Review 9.  The Neuroimmunology of Chronic Pain: From Rodents to Humans.

Authors:  Peter M Grace; Vivianne L Tawfik; Camilla I Svensson; Michael D Burton; Marco L Loggia; Mark R Hutchinson
Journal:  J Neurosci       Date:  2020-11-25       Impact factor: 6.167

Review 10.  Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis.

Authors:  Lauriane Delay; Gilson Gonçalves Dos Santos; Elayne Vieira Dias; Tony L Yaksh; Maripat Corr
Journal:  Rheum Dis Clin North Am       Date:  2021-02-26       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.